Shinichiro Hayashi Selected Research

Shinichiro Hayashi Research Topics

Disease

7	Lung Neoplasms (Lung Cancer) 09/2012 - 12/2003
7	Neoplasms (Cancer) 09/2012 - 08/2005
6	Inflammation (Inflammations) 01/2016 - 06/2003
4	Dermatomyositis (Dermatopolymyositis) 01/2022 - 02/2008
4	Hypertension (High Blood Pressure) 11/2016 - 01/2015
3	Necrosis 01/2022 - 01/2016
3	Asthma (Bronchial Asthma) 01/2016 - 01/2013
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2015 - 03/2003
3	Pneumonia (Pneumonitis) 01/2010 - 10/2005
2	Atrophy 01/2022 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2022 - 01/2020
2	AIDS-Related Complex (ARC) 04/2013 - 11/2012
2	Adenocarcinoma 09/2012 - 07/2010
2	Fibrosis (Cirrhosis) 05/2012 - 11/2011
2	Adenocarcinoma of Lung 10/2011 - 06/2008
2	Infections 01/2007 - 11/2002
1	Neuronal intranuclear inclusion disease 01/2022
1	Aspiration Pneumonia 01/2021
1	Sarcopenia 01/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Muscular Diseases (Myopathy) 12/2020
1	With Uniform Type 1 Fiber Congenital Neuromuscular Disease 12/2020
1	Ophthalmoplegia (External Ophthalmoplegia) 11/2020
1	Dysarthria (Spastic Dysarthria) 11/2020
1	Muscle Weakness 11/2020
1	Dermatitis 01/2020
1	Dyspnea (Shortness of Breath) 01/2020
1	Exanthema (Rash) 01/2020
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2020
1	Cytochrome-c Oxidase Deficiency 01/2019
1	Renal Hypertension 03/2017
1	Hyperuricemia 03/2017
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2017
1	Obesity 11/2016
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 09/2015
1	Body Weight (Weight, Body) 01/2015

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 04/2013 - 06/2003
7	Tyrosine Kinase InhibitorsIBA 01/2015 - 02/2007
4	Messenger RNA (mRNA)IBA 11/2012 - 12/2003
4	ErbB Receptors (EGF Receptor)IBA 09/2012 - 06/2008
3	UbiquitinIBA 01/2022 - 01/2020
3	SaltsIBA 11/2016 - 01/2015
3	Biomarkers (Surrogate Marker)IBA 04/2013 - 11/2008
3	DNA (Deoxyribonucleic Acid)IBA 09/2012 - 08/2005
2	Staphylococcal Protein A (Protein A)IBA 01/2022 - 01/2020
2	EnzymesIBA 01/2022 - 01/2020
2	nuclear matrix protein 2IBA 01/2022 - 01/2020
2	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2022 - 01/2021
2	Mi-2 antibodiesIBA 01/2022 - 01/2021
2	Alkaline PhosphataseIBA 01/2022 - 01/2021
2	AntibodiesIBA 01/2022 - 11/2020
2	AutoantibodiesIBA 01/2021 - 01/2020
2	Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA 04/2013 - 11/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 04/2013 - 11/2012
2	activity regulated cytoskeletal-associated proteinIBA 04/2013 - 11/2012
2	GalactokinaseIBA 04/2013 - 11/2012
2	Monoclonal AntibodiesIBA 09/2011 - 07/2010
2	hnRNP A2IBA 11/2008 - 08/2005
2	Heterogeneous-Nuclear Ribonucleoproteins (Informatin)IBA 11/2008 - 08/2005
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 11/2008 - 08/2005
2	Gefitinib (Iressa)FDA Link 06/2008 - 02/2007
2	Cisplatin (Platino)FDA LinkGeneric 01/2008 - 03/2003
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2007 - 11/2002
2	antileukinateIBA 10/2005 - 06/2003
1	Nucleosomes (Nucleosome)IBA 01/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	transcriptional intermediary factor 1IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	Succimer (Dimercaptosuccinic Acid)FDA Link 01/2022
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2021
1	ChromatinIBA 01/2021
1	Factor V (Coagulation Factor V)IBA 01/2021
1	tamibaroteneIBA 01/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2021
1	Pharmaceutical PreparationsIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Ligases (Synthetase)IBA 01/2021
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 12/2020
1	triadinIBA 12/2020
1	Ubiquitinated ProteinsIBA 11/2020
1	tiotropium-olodaterolIBA 01/2020
1	Tiotropium Bromide (Spiriva)FDA Link 01/2020
1	Janus Kinase InhibitorsIBA 01/2020
1	Bronchodilator Agents (Bronchodilators)IBA 01/2020
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2019
1	Uricosuric AgentsIBA 03/2017
1	BenzbromaroneIBA 03/2017
1	Febuxostat FDA Link 03/2017
1	Uric Acid (Urate)IBA 03/2017
1	Liposomes (Liposome)IBA 01/2016
1	Thymic Stromal LymphopoietinIBA 01/2016
1	Clodronic Acid (Clodronate)IBA 01/2016
1	Interleukin-33IBA 01/2016
1	DystrophinIBA 09/2015

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2008
2	Aftercare (After-Treatment) 01/2020 - 01/2007
1	Artificial Respiration (Mechanical Ventilation) 01/2021